Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 2

1(11.1%)

Phase 1

1(11.1%)

Phase 3

1(11.1%)

9Total

N/A(6)

Phase 2(1)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07189858Not ApplicableActive Not Recruiting

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada

Role: lead

NCT06702878Phase 3Active Not Recruiting

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Role: lead

NCT06867458Not ApplicableCompleted

Steriwave ICU Pilot Study

Role: collaborator

NCT06570252Not ApplicableNot Yet Recruiting

Preoperative Microbial Reduction of the Nasal Cavity With Antimicrobial Photodynamic Therapy (aPDT).

Role: collaborator

NCT05797818Phase 1Completed

Red Light Photobiomodulation and Topical Disinfectants

Role: lead

NCT05090657Phase 2Completed

Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures

Role: lead

NCT05184205Not ApplicableCompleted

Photodynamic Therapy for COVID-19 Prevention

Role: lead

NCT03270254Not ApplicableCompleted

Photodynamic Therapy Plus Root Debridement in Gum Disease Treatment V2

Role: collaborator

NCT01854619Not ApplicableUnknown

Photodynamic Therapy for the Treatment of Chronic Rhinosinusitis

Role: lead

All 9 trials loaded